Filing Details

Accession Number:
0001104659-23-087440
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-03 20:27:11
Reporting Period:
2023-08-01
Accepted Time:
2023-08-03 20:27:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1657312 Verona Pharma Plc VRNA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1836883 A. Kathleen Rickard 3 More London Riverside
London X0 SE1 2RE
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-08-01 19,736 $2.68 2,966,400 No 4 S Direct
Ordinary Shares Disposition 2023-08-02 13,728 $2.59 2,952,672 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  2. These sales were effected pursuant to a Rule 10b5-1 instruction entered into on May 14, 2021 solely with the intent to cover taxes in connection with the vesting of certainly previously reported Restricted Share Units.
  3. The price reported represents the sale price of the ADSs divided by eight (8).
  4. Consists of (i) 1,551,792 Ordinary Shares underlying RSUs (which are represented by 193,974 ADSs); and (ii) 1,400,880 Ordinary Shares underlying 175,110 ADSs.